UCalgary to collaborate on clinical trial assessing psychedelic treatments and cancer related distress
The study will assess which symptoms of cancer related distress are most responsive to a psilocybin-based treatment.
Stay updated with breaking news from Bob Dagher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study will assess which symptoms of cancer related distress are most responsive to a psilocybin-based treatment.
/PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental...
At noon, the Dow climbed 603 points to 35,183, while the S&P 500 added 40 points at 4,579 and the tech-heavy Nasdaq gained 32 points to 15,117
Dagher has supported and driven successful drug development programs from preclinical stages through Phase 4 clinical trials
Stocks rallied despite the 10-year Treasury yield rebounding after falling last week amid the virus threat